ArthritisVolume 2012 (2012), Article ID 560634, 28 pagesdoi:10.1155/2012/560634

Review Article

Prescribing Optimal Nutrition and Physical Activity as “First-Line” Interventions for Best Practice Management of Chronic Low-Grade Inflammation Associated with Osteoarthritis: Evidence Synthesis

Elizabeth Dean¹ and Rasmus Gormsen Hansen²

¹Department of Physical Therapy, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada, V6T 1Z3²Department of Physical Therapy, Ringsted and Slagelse Hospitals, Region Zealand, Denmark

Received 7 August 2012; Revised 23 November 2012; Accepted 24 November 2012

Academic Editor: Pierre Youinou

Copyright © 2012 Elizabeth Dean and Rasmus Gormsen Hansen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Low-grade inflammation and oxidative stress underlie chronic osteoarthritis. Although best-practice guidelines for osteoarthritis emphasize self-management including weight control and exercise, the role of lifestyle behavior change to address chronic low-grade inflammation has not been a focus of first-line management. This paper synthesizes the literature that supports the idea in which the Western diet and inactivity are proinflammatory, whereas a plant-based diet and activity are anti-inflammatory, and that low-grade inflammation and oxidative stress underlying osteoarthritis often coexist with lifestyle-related risk factors and conditions. We provide evidence-informed recommendations on how lifestyle behavior change can be integrated into “first-line” osteoarthritis management through teamwork and targeted evidence-based interventions. Healthy living can be exploited to reduce inflammation, oxidative stress, and related pain and disability and improve patients’ overall health. This approach aligns with evidence-based best practice and holds the promise of eliminating or reducing chronic low-grade inflammation, attenuating disease progression, reducing weight, maximizing health by minimizing a patient’s risk or manifestations of other lifestyle-related conditions hallmarked by chronic low-grade inflammation, and reducing the need for medications and surgery. This approach provides an informed cost effective basis for prevention, potential reversal, and management of signs and symptoms of chronic osteoarthritis and has implications for research paradigms in osteoarthritis.

1. Introduction

Best practice guidelines for chronic osteoarthritis focus on self-management, that is, weight control and physical activity, and on pharmacological support for inflammation and pain [1–5]. Despite such guidelines, authorities in the field report a lack of efficacy of current treatments and associated adverse effects [6], with some proposing even greater attention to self-management [7]. Further, although low-grade inflammation underlies chronic osteoarthritis comparable to other conditions with significant lifestyle-related components often presenting concurrently with osteoarthritis, this inflammation has not been a focus of best practice guidelines, particularly of its nonpharmacologic management.

To establish the prescription of optimal nutrition and physical activity as ‘‘first-line’’ interventions for low-grade inflammation associated with chronic osteoarthritis, we have synthesized three primary lines of support: (1) the literature that supports that the western diet and inactive lifestyle are proinflammatory, and a plant-based diet and regular physical activity are anti-inflammatory; (2) the literature supporting that low-grade inflammation is common across lifestyle-related conditions including osteoarthritis; and (3) evidence-informed recommendations for effecting lifestyle behavior change that can be readily integrated by health practitioners into ‘‘first-line’’ management. We conclude with implications for clinical practice and research with respect to its paradigm and avenues for future investigation.

2. Low-Grade Inflammation and Lifestyle

Human lifestyles have changed dramatically over millennia. With technological and economic advancements in western countries particularly over the past 60 years, lifestyle-related conditions are the leading causes of premature death [13]. With globalization, western diets coupled with inactivity have contributed largely to lifestyle-related conditions which are increasingly prevalent in middle- and low-income countries [14]. Some authorities have not only argued that western diets have contributed to poor chronic health outcomes, but that national food guidelines such as those in the United States have legitimized poor nutrition for several decades further contributing to the pandemic of lifestyle-related conditions [15]. In particular, poor nutritional quality has been reported to contribute to obesity [16], a primary risk factor for osteoarthritis [17], in addition to calorie density.

The factors associated with the typical western lifestyle that impact people’s health have been elucidated by cross-cultural studies including seminal work related to Mediterranean diet and exercise patterns and Asian lifestyles. The Mediterranean diet known to be health protective is largely plant based, favors olive oil over animal fats, and is high in fiber, vegetables, and fruits [18]. The China study [19–22] is a prime example. This comprehensive series of studies has shown the serious health consequences of high consumption of meat, dairy, fat, and refined grains and sugar (proinflammatory), and low consumption of whole grains, vegetables and fruits, and legumes and pulses (anti-inflammatory). This unnatural diet for humans contributes to low-grade systemic inflammation and oxidative tissue stress and irritation, placing the immune system in an overactive state, a common denominator of conditions with lifestyle components including arthritis [15]. Both high carbohydrate and high fat consumption contribute to inflammatory and oxidative stress even in healthy people [23]. This effect could accentuate inflammatory conditions such as lowering the threshold for local inflammation in arthritis. Diet-induced weight loss in people who are overweight reduces chronic low-grade inflammation as evidenced by signification reduced C-reactive protein, an inflammation biomarker [24].

In addition, sedentary living and inactivity are hallmarks of western culture. Evidence supports that inactivity is proinflammatory and augments oxidative stress [25], whereas activity when not excessive is anti-inflammatory [26, 27]. More commonly understood about exercise, however, is that inactivity weakens muscles and contributes to joint stress, in addition to reducing stimulation of synovial fluid which cushions the joints and protects the joint spaces [28]. Activity and exercise continue to be primarily recommended and prescribed to people with arthritis to offset these adverse effects. The anti-inflammatory effects of exercise, however, have been well established, and that for maximal anti-inflammatory benefit, broad-based training needs to include resistance and aerobic training [26, 27, 29]. Exercise induced analgesia [30] and stiffness associated with osteoarthritis may reflect both its anti-inflammatory and mechanical effects; however, exercise’s anti-inflammatory effects are not discussed in established practice guidelines [1–5]. In sum, the western lifestyle is inherently unhealthy, and lifestyles with nonwestern diets and greater activity levels are typically associated with better health outcomes, for example, traditional Asian and Mediterranean lifestyles [18, 31].

Other lifestyle traits common in western culture are also known to be proinflammatory. Smoking, for example, remains prevalent despite some success in recent decades in reducing its prevalence through public health campaigns. The chronic low-grade inflammation associated with smoking [32, 33] has been linked with inflammatory states associated with ischemic heart disease [34], rheumatoid arthritis [35], and osteoarthritis [36]. Low-grade inflammation has been associated with chronic sleep deprivation and stress [37–40] which are also common in western cultures. Given the well-documented link between low-grade inflammation and oxidative stress, and sleep deprivation and stress [41], a case can be made for assessing and addressing these in the initial assessment and in first-line management of chronic osteoarthritis. In addition, sleep deprivation and stress are common arthritic complaints secondary to discomfort and pain, lending further support for assessing sleep and stress in people with chronic osteoarthritis and intervening as indicated.

Thus, prescribing healthy living strategies in general as well as optimal nutrition (of which weight loss is an additional benefit) and regular physical activity are warranted as being first-line interventions in clinical practice guidelines for conditions such as osteoarthritis associated with chronic low-grade inflammation. These conditions are described in the next section and often coexist as comorbidities in people with osteoarthritis.

3. Low-Grade Inflammation and Lifestyle-Related Conditions Including Osteoarthritis

Figure 1 illustrates the interactive relationship among osteoarthritis, obesity, and physical inactivity. Obesity is an independent risk factor for osteoarthritis [84]. Although the mechanisms for this association are not completely understood, biomechanical loading and metabolic inflammation associated with excess adipose tissue and lipids may have a role. Pain associated with osteoarthritis leads to increasingly less activity and psychosocial and physical disability. Physical inactivity is an independent risk factor for inflammation due to the reduced expression of systemic and cellular anti-inflammatory mediators. Physiologic cyclic loading of cartilage tissue reduces the expression of proinflammatory mediators and decreases cytokine-induced extracellular matrix degradation. Physical inactivity reduces daily energy expenditure thereby promoting weight gain and continuation of the cycle. Emerging evidence indicates that osteoarthritis likely impedes the management of chronic metabolic conditions associated with prolonged negative lifestyle habits such as obesity, type 2 diabetes mellitus, and ischemic heart disease, because of its negative impact on physical activity.

Figure 1: Relationships among osteoarthritis, obesity, and physical inactivity and relationship to the etiology of chronic low-grade systemic inflammation. Adapted from [8].

Table 1 shows evidence for chronic low-grade inflammation and oxidative stress in people with osteoarthritis. Multiple comorbidities that share comparable underlying chronic low-grade inflammation and oxidative stress often coexist in individuals with chronic osteoarthritis, Examples of these conditions and synthesis of the evidence appear in Table 2, for example, atherosclerosis, chronic cancer, chronic obstructive lung disease, diabetes, hypertension, insulin resistance and metabolic syndrome, ischemic heart disease, obesity, and stroke. Almost 20 percent of American adults report having physician-diagnosed arthritis, and this is expected to increase over the next two decades [88]. Based on the Behavioral Risk Factor Surveillance System and National Health Interview Survey in the United States, individuals with osteoarthritis have a high incidence of other lifestyle-related conditions with inflammatory components that often present comorbidly with osteoarthritis (see examples in Table 2). Our search strategy used keywords including lifestyle-related conditions, chronic low-grade or chronic systemic inflammation. This synthesis of evidence reflects the literature indexed in established electronic data bases (MEDLINE and PubMed) and primarily published over the past five years. However, in several instances, important related work that was published earlier has been included in this evidence synthesis. The literature extracted represents a breadth of scholarly paradigms including clinical trials, cross-sectional population-based studies, experimental trials based on basic science and models and histological evidence, expert narrative reviews, randomized controlled clinical trials, and systematic reviews.

Table 1: Synthesis of evidence of chronic low-grade inflammation being associated with osteoarthritis.

Authors
Title
Evidence classification
Methods
Findings
Conclusion

Cecil et al., 2005 The Journal of Immunology [9]
Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products
Basic science study Experimental study
Analysis of human cartilage, cultured human articular chondrocytes, and recombinant human S100A11, soluble RAGE (advanced glycation end products), and RAGE-specific blocking antibodies
Normal human knee cartilages showed constitutive RAGE and S100A11 expression, and RAGE and S100A11 expression were upregulated in OA cartilages
Up-regulated chondrocyte expression in OA cartilage and RAGE signaling promote inflammation-associated chondrocyte hypertrophy

Rojas-Rodríguezet al., 2007 Medical Hypotheses [10]
The relation between the metabolic syndrome and energy-utilization deficit in the pathogenesis of obesity-induced osteoarthritis
Narrative review to examine a medical hypothesis: pathogenesis of obesity-induced OA may be explained by metabolic changes in striated muscle by interaction of insulin resistance and systemic inflammation in obese individuals
Evidence search strategy unspecified
Increased TH1 cytokines are produced by macrophages in presence of chronic infection and suppress insulin sensitivityMuscle cells and adipocytes are activated by inflammatory cytokines and contribute to chronic low-grade inflammation in apparently healthy obese individuals
The fatigue and muscle weakness induced by insulin resistance and inflammation in obese patients with metabolic syndrome (pro-inflammatory state) increase trauma to joints that result in breaking of tenoperiosteal junction and abrasive damage of cartilage

Schlesinger and Thiele, 2010Annals of Rheumatic Diseases [11]
The pathogenesis of bone erosions are in gouty arthritis
Review
Synthesis of mechanical, pathological, cellular, and immunological factors role in the pathogenesis of bone erosions in gouty arthritisSearch strategy unspecified
Monosodium urate crystal deposition associated with underlying OAGouty tophus and bone erosions associated with chronic low-grade inflammation
Tophus eroding underlying bone is pivotal for development of bone erosions in gouty arthritis

Smith et al. 1997 Journal of Rheumatology [12]
Synovial membrane inflammation and cytokine production in patients with early osteoarthritis
Clinical trial of patients with varying stages of early OA ()
Synovial membrane samples obtained from the knees of patients
Thickening of lining layer, increased vascularity, and inflammatory cell infiltration in synovial membranes; changes proportional to severityInflammatory markers increased in the synovial membranes of patients irrespective of degree of articular damage
Chronic inflammatory changes with production of pro-inflammatory cytokines characterize the synovial membranes of patients with early OALow-grade synovitis results in the production of cytokines that may contribute to OA pathogenesis

Table 2: Synthesis of evidence of chronic low-grade inflammation being associated with conditions that may coexist with a diagnosis of osteoarthritis.

Alzheimer’s disease

Giunta et al., 2008Journal of Neuroinflammation [42]
Inflammaging as a prodrome to Alzheimer’s disease
ReviewThe immunological aspects of aging related to Alzheimer’s Disease (AD), that is, the increased innate immunity by cells of the mononuclear
Articles reported the characterization the aging immune response related to the concept of inflammaging (low-grade chronic up-regulation of pro-inflammatory response)Specific search strategy unspecified
Conditions of increased innate immune response with overproduction of pro-inflammatory proteins are related to healthy aging and ADPeople who age “well” have anti-inflammaging mechanisms and biomarkers that counter the adverse immune response of inflammaging
Countering inflammaging may prevent or treat the symptoms of AD

Veerhuis, 2011Current Alzheimer Research [43]
Histological and direct evidence for the role of complement in the neuroinflammation of AD (AD-Alzheimer’s disease)
Histologic and direct evidence
Synthesis and secretion of reactive oxygen species (ROS), cytokines, chemokines, and other potentially neurotoxic agents by the glial cells implicated in AD
In AD, there are brain areas with amyloid deposits and complement activation productsComplement regulatory proteins are found in brain parenchyma and are upregulated, especially under inflammatory conditions
Evidence from immunohistochemical, in vitro and animal studies points to role for complement activation In chronic low-grade inflammatory conditions, such as in AD, complement activation proceeds, leading to sustained glial cell activation and neurodegenerative changes

Candore et al., 2010Current Pharmacology Designs [44]
Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement
Review
Search strategy unspecified
Evidence supports that low-grade systemic inflammation characterizes ageing and that inflammatory markers are significant predictors of mortality with ageing
Elucidation of ageing pathophysiology to disentangle age-related low-grade inflammation will provide evidence to develop drugs to delay ageing process

Asthma

Chou et al., 2011Journal of Sex Medicine [45]
Asthma and risk of erectile dysfunction—a nationwide population-based survey
Population-based surveybetween 2000 and 2007, newly diagnosed asthma cases identified (18–55 y) ()Control cohort (without asthma) matched for age and co-morbidities ( 13,836)
Cohorts were followed for evidence of erectile dysfunction (ED)
Subjects with asthma experienced 1.9-fold increase in ED independent of age and comorbidity compared with control cohort
Asthma may be an independent risk factor for ED (increasing with asthma severity)Chronic systemic inflammation is implicated in this linkage

Dixon, 2012Expert Reviews in Respiratory Medicine [46]
The treatment of asthma in obesity
Expert review
Epidemiology of obesity has influenced epidemiology of other conditions, for example, asthmaObesity major risk factor for new asthmaSearch strategy not specified
Mechanical factors, metabolic inflammation, and other comorbidities probably contribute to asthma
Therapies need to be developed and tailored to various underlying mechanisms

Juel et al., 2012Journal of Asthma and Allergy [47]
Asthma and obesity: does weight loss improve asthma control? A systematic review
Systematic review
Obesity associated with high asthma incidence and poor controlReview of knowledge on effect of weight reduction on asthma control based on systematic searches using the PubMed database and relevant MeSH terms
Weight loss in obese individuals associated with 48%–100% remission of asthma symptomsWeight loss associated with improved lung function and airway responsiveness to inhaled methacholine
Weight loss consistently reduces asthma symptomsImproved asthma control including objective measures of disease activity

Atherosclerosis

Gu et al., 2012Atherosclerosis [48]
Psychological stress, immune response, and atherosclerosis
Review
Synthesis of evidences that various immunological factors are transformed under prolonged psychological stress by causing vascular low-grade inflammation
Evidence supports expression of pro- and anti-inflammatory cytokines by stress hormones (catecholamines and corticosteroids)
Elucidation of two-way communication between neuroendocrine and immune systems Implications for targeted treatment strategies

Kucharz, 2012Medical Hypotheses [49]
Chronic inflammation-enhanced atherosclerosis: can we consider it a new clinical syndrome?
Narrative reviewMedical hypothesis:incidence of cardiovascular disease (CVD) in patients with chronic autoimmune disorders is much higher than in general populationCVD is caused by accelerated atherosclerosis, in which chronic inflammation is implicated
The literature search strategies unspecified
Chronic inflammation-enhanced atherosclerosis syndrome is proposed as a separate syndrome occurring in patients suffering of chronic inflammation
Atherosclerosis as an inflammatory disease and chronic extravascular inflammation have common mechanisms resulting in an increase in atherosclerosis and its sequelae, CVD

Lu et al., 2012Psychosomatic Medicine [50]
Unpredictable chronic mild stress promotes atherosclerosis in high cholesterol-fed rabbits
Experimental
Chronic psychological stress associated increased with risk of atherosclerosisStudy of effects of chronic stress on atherogenesis in rabbitsRabbits fed cholesterol-rich diet for 4–16 wks
High-cholesterol feeding resulted in hypercholesterolemia and formation of atherosclerotic plaques in the aortaHigh-cholesterol diet increased plaque size and instability
Findings support that atherosclerosis is augmented by chronic psychological stress, due to increased vascular inflammation and decreased endothelial nitric oxide bioavailability

Ortega et al., 2012Atherosclerosis [51]
White blood cell count is associated with carotid and femoral atherosclerosis
Clinical studySubjects with dyslipidemia () and sex-matched normolipidemic subjects ()
Examined the association between inflammatory markers and atherosclerosis evidenceCarotid and femoral arteries were imagedWhite blood cell counts (WBCC) were obtained
Chronic low-grade inflammation is associated with atherosclerosisWBCC associated with measures of atherosclerosis independent of risk factors
WBCC is a useful and easy marker of atherosclerosis, consistent with its inflammatory basis

Pinto et al., 2012Current Pharmaceutical Design [52]
Effects of physical exercise on inflammatory markers of atherosclerosis
Expert narrative review
Synthesis of research related to regular physical training and low-grade inflammationSearch strategy unspecified
Physical exercise could be considered a useful weapon against local vascular and systemic inflammation in atherosclerosis.
Several mechanisms explain the positive effect of chronic exercise Including decreased inflammation and endothelial dysfunction, and modulated progression of underlying disease progress

Cancer

Correa and Piazuelo, 2012 [53]
The gastric precancerous cascade
Lead articleState-of-the-art
Review of experimental articles that support the steps in the gastric precancerous cascadeSearch strategy unspecified
Inflammatory changes may persist throughout the precancerous processFirst recognized histological change is active chronic inflammation which is the first step in the precancerous cascade
Most promising strategy for control of the condition is prevention, augmented by prolonging the pre-cancerous process which requires an understanding of the precancerous cascadeLesion detected earliest in inflammation

Peters et al. 2012Stress [54]
Chronic psychosocial stress increases the risk for inflammation-related colon carcinogenesis in male mice
Experimental Animal modelInvestigated the effects of chronic psychosocial stress in male mice with artificially induced colorectal cancer (CRC)
Outcomes based on colonoscopic evaluation and protein analysis
CSC mice showed accelerated macroscopic lesionsCSC mice showed more cell dysplasia than the single-housed control (SHC) miceAbnormal protein expression was also greater in CSC than SHC mice
Findings consistent with the fact that chronic psychosocial stress increases the likelihood of developing an irritable bowel, and multiple types of malignant neoplasms, including CRC

Chronic obstructive lung disease

Cox jr 2012Dose Response [55]
Dose-response thresholds for progressive diseases
Narrative reviewTo provide evidence base for framework
Framework proposed for understanding how exposure can destabilize normally homeostatic feedback control systems and create sustained imbalances and elevated levels of disease-related
The resulting model, called the alternative equilibria (AE) theory, implies the existence of an exposure threshold below which transition to the alternative equilibrium (potential disease)
These predictions may help to explain patterns observed in experimental and epidemiological data for diseases such as COPD, silicosis, and inflammation-mediated lung cancer

variables, by creating a new, locally stable, alternative equilibrium for the dynamic system, in addition to its normal (homeostatic) equilibriumSearch strategy unspecified
state will not occur, and once exceeded, progression to the alternative equilibrium continues spontaneously, even without further exposure

Lindberg et al., 2011COPD [56]
Co-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung function
Clinical trialSubjects with COPD from obstructive lung disease in northern Sweden cohort followed in 2002–2004() Gender and age matched reference subjects without COPD()
To evaluate if conditions associated with systemic inflammation (e.g., cardiovascular diseases, diabetes, chronic rhinitis, and gastroesophageal reflux, are overrepresented in patients with COPDAnalysis based on interview data on co-morbidity and symptoms
Prevalence of chronic rhinitis and gastroesophageal reflux (GERD) was higher in COPD compared to reference groupIn restrictive lung function, the prevalence of chronic rhinitis, cardiovascular disease, hyperlipemia, and diabetes was higher compared to reference group In COPD and heart disease, chronic rhinitis and/or GERD were proportionately higher than reference group
Co-morbid conditions associated with systemic inflammation, for example, cardiovascular disease, chronic rhinitis, and gastroesophageal reflux, were common in patients with COPDOverlap between heart disease, chronic rhinitis and GERD was large in COPD

ten Hacken, 2009Proceeding of the American Thoracic Society [57]
Physical inactivity and obesity: relation to asthma and chronic obstructive pulmonary disease?
ReviewTo summarize the available literatureregarding the potential role of physical inactivity and obesity in asthma and COPD and to examine their contribution to systemic inflammation
Physical inactivity and obesity are associated with low-grade systemic inflammation that may contribute to the inflammatory processes present in many chronic diseasesSearch strategy unspecified
High prevalence of asthma in obesity In chronic obstructive pulmonary disease (COPD), physical inactivity has been demonstrated This was associated with a higher degree of systemic inflammation,
Elucidation of the independent relationship between physical inactivity and obesity with systemic inflammation, performance-based studies of physical inactivity in asthma and COPD are needed

independent of body mass index Obesity is associated with the chronic obstructive phenotype and features of the metabolic syndrome

Wouters et al., 2009Proceedings of the American Thoracic Society [58]
Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection?
ReviewState-of-the-art
To examine the association between asthma and chronic obstructive pulmonary disease (COPD)Search strategy unspecified
Spillover of inflammatory mediators into the circulation considered the source of systemic inflammation in these conditions
Nature of systemic inflammation remains unclearAdipose tissue mediated inflammation is one explanation

Diabetes mellitus (types 1 and 2)

Chang et al., 2012 in press Acta Diabetologica [59]
Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus
Clinical trialSubjects: patients with type 2 diabetes mellitus ()
To examine whether short- or long-term glycemic fluctuations could induce oxidative stress and chronic inflammation, relationships between glycemic variability, oxidative stress markers, and high-sensitivity C-reactive protein (hs-CRP) were studied
Relationships between markers for short- and long-term glycemic control remained significant with respect to oxidative stress and chronic inflammation, after adjusting for other markers of diabetic control
Both acute and chronic blood glucose variability can induce oxidative stress and chronic inflammation

van Bussel et al., 2012 in pressNutrition and Metabolism in Cardiovascular Disease [60]
Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: The EURODIAB study
Clinical trialTo investigate the association between nutrient consumption and biomarkers of endothelial dysfunction (ED) and low-grade inflammation (LGI) in subjects with type 1 diabetes ()
A healthy diet has been inversely associated with ED and LGINutrient consumption and lifestyle risk factors were measured in 1989 and 1997Biomarkers of ED and LGI (C-reactive protein, interleukin 6, and tumour necrosis factor α) were measured in
Consumption of less fibre, polyunsaturated fat and vegetable protein, and more cholesterol over the study period was associated with more ED and LGI
Following dietary guidelines in type 1 diabetes may reduce cardiovascular disease risk by favourably affecting ED and LGI

1997 and averaged into -scores. The nutrient residual method was used to adjust individual nutrient intake for energy intake

Fibromyalgia

Kadetoff et al., 2012Journal of Neuroimmunology [61]
Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels
Clinical trialSubjects: patients with FM
To assess intrathecal concentrations of pro-inflammatory substances in patients with FM
Elevated cerebrospinal fluid and serum concentrations of interleukin-8, but not interleukin-1beta, in FM patients
Findings consistent with a central pro-inflammatory component

Ortega et al. 2012Journal of Medical Science and Sports [62]
Aquatic exercise improves the monocyte pro- and anti-inflammatory cytokine production balance in patients with fibromyalgia (FM)
Clinical trialSubjects: women patients with FM and age-matched control group of healthy women
Evaluated the effect of a pool-aquatic exercise program (8 months, two weekly 60 min sessions) on the inflammatory cytokine production by isolated monocytes, and on the serum concentration of C-reactive protein (CRP)
Monocytes from FM patients released more inflammatory cytokines than those from women in control groupFM women had high circulating concentrations of CRP Increased IL-6 with a concomitant decreased TNFα spontaneous release was found after 4 monthsAnti-inflammatory effect of the exercise program was also corroborated by a decrease in the circulating CRP concentration
FM is associated with chronic inflammation that can be offset with physical exercise such as aquatic exerciseExercise also improved the health-related quality of life of the FM patients

Hypertension

Berni et al., 2012 Journal of Human Hypertension [63]
Renal resistive index and low-grade inflammation in patients with essential hypertension
Clinical trialSubjects: hypertensive patients (; 57 ± 14 years, 61 males)without diabetes, renal
To study the relationship between RRI and serum hsCRP in hypertensives with preserved renal function, without
Patients with pathologic RRI () were older and had higher hsCRP levels compared with patients with normal RRI, as well as patients
HsCRP is a predictor of both pathologic RRI and decreased RV/RRI, even after adjustment In essential hypertension,

failure, microalbuminuria, or major inflammatory disease
microalbuminuria
with decreased RV/RRI ()HsCRP was directly related with RRI and inversely with RV/RRI
low-grade inflammation is associated with tubulointerstitial damage

He et al., 2012Journal of Hypertension [64]
Metformin-based treatment for obesity-related hypertension: a randomized, double-blind, placebo-controlled trial
Randomized, double-blind, placebo-controlled trialSubjects: participants randomized to metformin () and participants randomized to placebo ()
To explore whether metformin-based treatment (which reduces weight and inflammation in diabetes) benefits obesity-related hypertension without diabetes24 week drug trial
Metformin compared with placebo did not have effects on blood pressure, blood glucose, and high-density or low-density lipoprotein cholesterol, but it did reduce total serum cholesterol Metformin reduced weight, BMI, waist circumference and both subcutaneous and visceral adiposity and lowered serum high-sensitivity C-reactive protein
Results supported an inflammatory component of hypertension in patient who are obese, that was amenable to metformin that targets inflammation

Sari et al. 2011Clinical Experimental Hypetension [65]
The effect of quinapril treatment on insulin resistance, leptin and high sensitive C-reactive protein in hypertensive patients
Clinical trialSubjects: hypertensive patients () and control subjects ()
To evaluate the effect of quinapril on HOMA-IR, high sensitive C-reactive protein, and leptinBlood pressure, leptin, high sensitive C-reactive protein, and HOMA-IR were determined at baseline and after 3 months of quinapril treatment
After treatment with quinapril HOMA-IR, high sensitive C-reactive protein, and leptin were decreased in hypertensive patients
Quinapril may be used as a therapy for improving blood pressure as well as the insulin resistant, hyperleptinemic, and low-grade inflammatory state in hypertension

Sugiura et al. 2011Journal of Clinical Lipidology [66]
Impact of lipid profile and high blood pressure on endothelial damage
Clinical trialJapanese male outpatients with grade I or II hypertension,
Blood was sampled for laboratory analysis and endothelial
Total cholesterol to high-density lipoprotein cholesterol ratio
Impaired endothelial function was associated with increased

along with gender and age-matched normotensive subjects (both = 25)
function was assessed by flow-mediated dilation (FMD)
(total-C/HDL-C) was inversely correlated with the FMD value and positively correlated with both malondialdehyde-modified low-density lipoprotein and high-sensitivity C-reactive protein valuesto those in normotensive subjects with high total-C/HDL-C
total-C/HDL-C values, possibly as a result of increased vascular oxidative stress and inflammationIn early stages of atherosclerosis, the impact of both total-C/HDL-C and BP may be similar in terms of endothelial damage

Insulin resistance/metabolic syndrome

Piya et al., 2006 in press Journal of Endocrinology [67]
Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin
Review
To examine impact of nutrients such as glucose and lipids on inflammatory pathways, specifically within adipose tissue, and how these influence adipokine inflammation and insulin resistanceSearch strategy unspecified
Through overnutrition, glucose, lipids, and endotoxin affect different tissues to mediate an aberrant inflammatory response and augment pathogenesis of insulin resistance and metabolic disease
Evidence supports the persistent insults from dysfunctional diets that need to be the targets of interventionReducing the burden in this way may impact people’s long-term health

Shoelson et al., 2006Journal of Clinical Investigation [68]
Inflammation and insulin resistance
Review
Evidence has linked inflammation to the pathogenesis of type 2 diabetes (T2D)Search strategy unspecified
With discovery of an important role for tissue macrophages, these findings are helping to reshape thinking about how obesity increases the risk for T2D and metabolic syndrome
The evolving concept of insulin resistance and T2D as having immunological components and as improving the picture of how inflammation modulates metabolism provides new opportunities for using anti-inflammatory strategies to address metabolic consequences of excess adiposity

Ischemic heart disease

Simon, 2012Circulation Journal [69]
Inflammation and vascular injury
Review
To examine thecentral role of inflammation in vascular injury and repairSearch strategy unspecified
Binding site for GPIbαin Mac-1 shows that leukocyte engagement of platelet GPIbαvia Mac-1is critical for the biological response to vascular injury, thrombosis, vasculitis, glomerulonephritis, and multiple sclerosis
Almost all inflammation is platelet dependentLigand engagement of Mac-1 initiates a novel gene that promotes inflammation

Kalogeropoulos et al., 2012  Heart Failure Clinics [70]
From risk factors to structural heart disease: the role of inflammation
Review
Review strategy unspecified
Elevated levels of circulating proinflammatory cytokines and adipokines have been repeatedly associated with increased risk for clinically manifest (Stage C) heart failure in large cohort studies. The role of low-grade, subclinical inflammatory activity in the transition from risk factors (Stage A heart failure) to structural heart disease (Stage B heart failure) is less well understood
Recent evidence suggests that chronic low-grade inflammatory activity is involved in most mechanisms underlying progression of structural heart disease, including ventricular remodeling after ischemic injury, response to pressure and volume overload, and myocardial fibrosisInflammation also contributes to progression of peripheral vascular changes

Vizzardi et al. 2011Panminerva Medica [71]
Helicobactor pylori and ischemic heart disease
Review
Many studies have been performed on the relationship between infection from Helicobacter pylori and atherosclerotic diseases, like stroke and ischemic heart disease
Review of the literature that has investigated the role of HP in the development and pathogenesis of CAD. Infection could lead to IHD through pathways such as endothelial cells
Results from these studies have raised new perspectives on coronary heart disease, especially regarding the possibility of modifying the clinical history of the disease through eradication of these

Some infections could have a role on the genesis and development of damage to the vascular wall and of atheromatous plaque HP could influence the development of IHD through various pathwaysSearch strategy unspecified
colonization, changes in the lipid profiles, increased coagulation and platelet aggregation levels, induction of molecular mimicry mechanisms, and the promotion of a low-grade systemic inflammation
infective microorganismsFurther studies indicated

Kidney disease

Kang et al., 2012Journal of Korean Medical Science [72]
Low-grade inflammation, metabolic syndrome and the risk of chronic kidney disease: a 2005 Korean National Health and Nutrition Examination Survey
Cross-sectional studySubjects: adults registered in the national survey ()
To examine the relationship between white blood cell (WBC) count and chronic kidney disease ≥stage 3Measures of glomerular filtration rates
Low-grade inflammation is associated with chronic kidney disease in people with metabolic syndrome ≥stage 3
Low-grade inflammation associated with chronic kidney disease ≥stage 3 in people with metabolic syndrome suggests new treatment approaches

Kocyigit et al., 2012American Journal of Nephrology [73]
Early arterial stiffness and inflammatory bio-markers in normotensive polycystic kidney disease patients
Clinical trialCross-sectional designPatients () with autosomal-dominant kidney disease (ADPKD) (42% males, 36.6 ± 9.9 years, no blood pressure medication) and healthy controls () (44% males, 35.4 ± 6.4 years)
To clarify temporal relationship between ADPKD, hypertension, and the loss of renal function, patients with early-stage ADPKD who did not yet have hypertension were examinedPulse wave velocity (PWV), cardiac morphology and function, aortic elastic indexes, estimated glomerular filtration rate (eGFR), 24-hour ambulatory blood pressure, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and highly sensitive C-reactive protein (hs-CRP) were measured
Despite normal blood pressure, aortic stiffness index and pulse wave velocity values were increased in patients compared to controls In univariate analysis, IL-6, TNF-α, hs-CRP, and eGFR were correlated with PWV PWV is predicted by IL-6, TNF-α, and hs-CRP
Increased arterial stiffness and pulse wave velocity are early manifestations of ADPKD appearing before hypertension or reduced eGFRThese vascular abnormalities are related to signs of systemic low grade inflammationFindings support a common pathophysiological mechanism apparently present also in other vascular diseases

Luis- Rodríguez et al., 2012World Journal of Diabetes [74]
Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy
Review (experimental and clinical studies)
To identify pathogenic pathways for earlier diagnosis and targeting novel treatmentsSearch strategy unspecified
Activation of innate immunity with development of a chronic low grade inflammatory response is a recognized factor in the pathogenesis of diabetic nephropathyExperimental and clinical studies support various inflammatory molecules and pathways in the pathoetiology of diabetic neuropathy
Increased knowledge and understanding of inflammatory mechanisms are needed to augment clinical interventions for this complication

Tang et al., 2012International Journal of Nephrology [75]
Inflammation and oxidative stress in obesity-related glomerulopathy
Review
To focus on inflammation and oxidative stress in the progression of obesity-related glomerulopathy and possible interventions to prevent kidney injury in obesitySearch strategy unspecified
Obesity-related glomerulopathy is a major cause of end-stage renal disease.Obesity has been considered a state of chronic low-grade systemic inflammation and chronic oxidative stressAugmented inflammation in adipose and kidney tissues promotes the progression of kidney damage in obesity
Adipose tissue, which is accumulated in obesity, is a key endocrine organ that produces multiple biologically active molecules, including leptin, adiponectin, and resistin, that affect inflammationOxidative stress is also associated with obesity-related renal diseases and may trigger the initiation or progression of renal damage in obesityBoth inflammation and oxidative stress induce damage to renal tubule and glomerulus and result in endothelial dysfunction in the kidney Anti-inflammation and antioxidant

interventions may be therapies to prevent andtreat obesity-related renal diseases

Obesity

Hulsmans et al., 2012PLoS One [76]
Interleukin-1 receptor-associated kinase-3 is a key inhibitor of inflammation in obesity and metabolic syndrome
Experimental and clinical studiesObese individuals ( and 102) and age-matched controls ()
Cluster of molecules were studied that support interactions between the stress conditions of low-grade inflammation and oxidative stress in monocytesEffect of three month weight loss after bariatric surgery examined
Visceral obesity is associated with type 2 diabetes and metabolic syndromeLow-grade chronic inflammation and oxidative stress synergize in obesity and obesity-induced disordersOdds ratio of high-sensitivity C-reactive protein, a widely used marker of systemic inflammation, was 4.3
Weight loss was with a lowering of systemic inflammation and a decreasing number of metabolic syndrome componentsAn increase in reactive oxygen species in combination with obesity-associated low adiponectin and high glucose and interleukin-6 was identified as the cause of the decrease in IRAK3 in THP-1 cells in vitro

Issa and Griffin, 2012Pathobiology of Aging and Age Related Diseases [8]
Pathobiology of obesity and osteoarthritis: integrating biomechanics and inflammation
Review
Search strategy unspecified
Pathobiology of obesity and osteoarthritis (OA) was examined, as well as literature the underlying systemic inflammation, its relationship to inactivity, and their interactions
Inflammation is central to progression of the disease cycle involving obesity, osteoarthritis, and physical inactivityMetabolic inflammation is believed to contribute to metabolic inflexibility and on-going production of pro-inflammatory mediatorsFindings support that metabolic inflammation increases OA risk

Rico-Rosillo and Vega-Robledo, 2012Revista Médica del Instituto Mexicano del Seguro Social [77]
New trends in macrophages, inflammation and adipose tissue
Review
To highlight the macrophage participation in the generation of obesity-induced inflammationSearch strategy unspecified
Accumulating evidence suggest the involvement of adipose tissue derived proteins, collectively known as adipokines as well as other factors produced in this tissue by cells besides adipocytes, like fibroblasts, lymphocytes, and macrophagesObesity burden on health extends across multiple organs systems and diseases (atherosclerosis, coronary heart diseases, osteoarthritis, diabetes, hypertension, and dyslipidemia)
Obesity is considered a low-inflammatory conditionAn increasing number of reports suggest that the adipose tissue itself might be a source of pro-inflammatory factors and a target of inflammatory processesEvidence supports involvement of adipose tissue-derived proteins, collectively known as adipokines and other factors produced in this tissue by cells besides adipocytes (fibroblasts, lymphocytes, and macrophages)

Stienstra, 2007PPAR Research [78]
PPARs, obesity, and inflammation
Review
To address the role of peroxisome proliferator-activator receptors (PPARs) in obesity-induced inflammation specifically in adipose tissue, liver, and the vascular wallSearch strategy unspecified
Changes in inflammatory status of adipose tissue and liver with obesity supports co-existent chronic low-level inflammation Various molecular mechanisms have been implicated in obesity-induced inflammation (some modulated by PPARs)PPARs modulate the inflammatory response, hence, constitute a therapeutic target to mitigate obesity-induced inflammation and its consequences
Obesity is accompanied with fat storage in tissues other than adipose tissue (liver and skeletal muscle) which may lead to local insulin resistance and stimulate inflammationObesity changes the morphology and composition of adipose tissue, leading to changes in its protein production and secretion including pro-inflammatory mediators

Tajik et al. 2012 in press Journal of Endocrinological Investigation [79]
Effect of diet-induced weight loss on inflammatory cytokines in obese women
Clinical trialSubjects: Premenopausal obese women (body mass index ≥ 30) aged 21 to 54 years without diabetes, hypertension, or hyperlipidemia ()
To evaluate changes in pro/anti-inflammatory adipocytokines and metabolic profile after moderate diet-induced weight, anthropometric parameters, lipid and glucose profiles, IL-6, IL-10, and IL-18 were measuredSubjects then entered into a weight reduction program (3 months)
Body mass index, waist circumference, triceps skinfold thickness, total cholesterol, triglyceride, and fasting plasma glucose decreased, while HDL-cholesterol increasedWhile plasma levels of IL-6 and IL-18 decreased, no change was observed in circulating levels of IL-10
Obesity is associated with low-grade systemic inflammation which has been linked to the increased risk of cardiovascular disease and type II diabetes in obese patientsimproved body composition induced by restriction of energy intake is associated with favorable serum concentrations of IL-6 and IL-18 in obese women

Rheumatoid arthritis

Gremese and Ferraccioli 2011Autoimmunology Review [80]
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk
Review
Rheumatoid arthritis (RA) patients have an incidence of cardiovascular (CV) diseases two-fold that of the general population Atherosclerosis, the main determinant of CV morbidity and mortality, and carotid intima-media thickness, an early preclinical marker of atherosclerosis, also occur early on in RASearch strategy unspecified
CV risk factors seem to have the same prevalence in RA and non-RA patients, thus they do not fully explain increased CV burden, suggesting that RA inflammation and therapies play a role in increasing CV risk in these patientsThe metabolic syndrome (MetS) and fat tissue are likely major players in this complex networkThe association of MetS and atherosclerosis is partly mediated by altered secretion of adipokines by adipose tissue and,
Obesity is now regarded as a systemic, low-grade inflammatory state, and inflammation as a link between obesity, metabolic syndrome, and CV diseasesTo control CV risk, data support the necessity of “tight control” of inflammation from both RA and MetS

on the other hand, there are evidence that adipokines may play a role in inflammatory RA

Prete et al., 2011Autoimmunology Review [81]
Extra-articular manifestations of rheumatoid arthritis: An update
ReviewRheumatoid arthritis (RA) is an immune-mediated disease involving chronic low-grade inflammation that may progressively lead to joint destruction, deformity, disability, and even deathDespite its predominant osteoarticular and periarticular manifestations, RA is a systemic disease often associated with cutaneous and organ-specific extra-articular manifestations (EAM)
Current Reviews knowledge about EAM in terms of frequency, clinical aspects, and current therapeutic approaches. In an initial attempt at a classification, we separated EAM from RA co-morbidities and from general, constitutional manifestations of systemic inflammation. EAM was classified as cutaneous and visceral forms, both severe and not severeSearch strategy unspecified
In aggregated data from 12 large RA cohorts, patients with EAM, especially the severe forms, were found to have greater co-morbidity and mortality than patients without EAM
Understanding the complexity of EAM and their management remains a challenge for clinicians, especially since the effectiveness of drug therapy on EAM awaits study

Stroke

Denes et al. 2011Cerebrovascular Disease [82]
Interleukin-1 and stroke: biomarker, harbinger of damage, and therapeutic target
Review
Inflammation is established as a contributor to cerebrovascular diseaseRisk factors for stroke include many conditions associated with chronic or acute inflammation, and inflammatory changes in the brain after cerebrovascular events contribute
Evidence supports importance of peripherally-derived immune cells and inflammatory molecules in various central nervous system disorders, including strokeInflammatory cytokine, interleukin-1 (IL-1), plays a pivotal role in both local and systemic
Blockade of IL-1 could be therapeutically useful in several diseases which are risk factors for strokeThere is considerable preclinical and clinical evidence that inhibition of IL-1 by IL-1 receptor antagonist may be valuable in the management of acute stroke

to outcome in experimental studies, with growing evidence from clinical research Search strategy unspecified
inflammation and is a key driver of peripheral and central immune responses to infection or injury

Wu et al., 2012American Journal of Rhinological Allergy [83]
Risk of stroke among patients with rhinosinusitis: a population-based study in Taiwan
Population-based trialProspective cohort studyPatients in Taiwan (Longitudinal Health Insurance Database 2005 (LHID2005)) who had received a diagnosis of rhinosinusitis ( 53,653) between January 1, 2004 and December 31, 2005Control group (1 : 4) drawn from the same database was matched for age and gender ( 214,624)
Each patient was followed up using data entered until the end of 2006Proportional hazard regressions were performed to evaluate the hazard ratios (HRs) after adjusting for potential confounding factors
Patients with rhinosinusitis were more likely to suffer strokes than the control population, after adjusting for potential confounders
Both acute and chronic sinusitis are risk factors or markers for stroke that is independent of traditional stroke risk factorsFurther epidemiological research is warranted

Although the degree to which the typical western lifestyle explains the prevalence of osteoarthritis is unclear, maximizing healthy living may have the greatest potential for minimizing its risk, its impact, and long-term outcomes including life-long health and wellbeing compared with invasive interventions including drugs and surgery and their related sequelae and side effects.

Overweight is now considered a leading condition associated with marked inflammation followed by arthritis, heart disease, and type 2 diabetes mellitus [89]. The mechanism whereby overweight contributes to inflammation is reported to involve high fat content of the diet [90]. Thus, promoting healthy weight through healthy nutrition in addition to regular physical activity and exercise is critically important to promote a maximally anti-inflammatory systemic environment to offset low-grade inflammation as well as to achieve weight loss.

4. Integration of Lifestyle Behavior Change into ‘‘First-Line’’ Management

For lifestyle behavior change to constitute ‘‘first-line’’ management as the literature would support, the health care team overall needs to share this goal and practice in partnership rather than in the conventional siloed care. The three primary health professions excluding, dentistry and pharmacy, include physicians, nurses, and physical therapists. Traditionally, physicians are highly trained in administration of invasive interventions, that is, drugs and surgery. Nurses have assumed a role in patient education over the years along with psychosocial considerations of patient care. Of the established health professions, physical therapy is the leading nonpharmacologic profession that is particularly well positioned to assume such an education role for patients related to healthy lifestyles and exercise [91, 92].

Consistent with the 21st century epidemiological trends, physical therapists are moving toward a model of care based on health (International Classification of Functioning, Disability and Health) [91, 93], which includes initiating and supporting behavior change such as optimal nutrition, weight reduction, reduced sedentary activity, and increased physical activity. With respect to nutrition, basic assessment can be done and education undertaken regarding patients’ knowledge with the inflammatory characteristics of their diets and incorporating anti-inflammatory foods (see Table 3).

Table 3: Pro- and Anti-inflammatory Foods (Source: reviews Beck, 2010; Daniluk, 2011; Weil, 2012; [85–87]).

Pro-inflammatory Foods
Anti-inflammatory Foods

Alcohol
The “anti-inflammatory” nutritional plan includes:

    Regular high consumption irritates esophagus, larynx and liver which can lead to chronic inflammation which promotes tumor growth at sites of chronic irritation
    Avoidance of sweets and sugar

    Avoidance of high refined foods such as processed foods (white bread and rice, and pasta),     Minimal fats (virgin olive oil okay as it has excellent anti-inflammatory properties)     High fiber foods including dark breads such as rye and pumpernickel     No alcohol

Cooking oils
Recommended anti-inflammatory foods:

    A diet of high imbalance of omega-6 to omega-3 ratio promotes inflammation (e.g., heart disease and cancer)
Oatmeal (not instant)     Asparagus, avocado, beets, Brussell sprouts, broccoli, caulflower, kale, parsnip, spinach     Romaine lettuce     Berries     Strawberries, blueberries, raspberries, blackberries     Green apples, oranges, pears, lemons, cantaloupe melon     Olives     Unsalted raw nuts     Sunflower seeds     Extra virgin olive oil     Water     Green tea     Beans, chickpeas, black beans     Lentils     Low fat turkey/chicken     Eggs     Salmon     Low sodium tuna packed in water     Dairy     Low-fat milk products are acceptable particularly plain yogurt, cottage and solid cheeses, if any, like Swiss or cheddar; feta

Dairy products

    Meat (commercially produced meats where animals are fed grains such as soy beans and corns (a diet high in inflammatory omega-6 fatty acids and low in anti-inflammatory omega-3 fatty acids; also, these animals have limited exercise and raised to gain excess fat, ending up with high saturated fats. To make the animals grow faster and prevent them from getting sick, they are injected with hormones and fed antibiotics.) Red meats (beef, lamb and pork) and processed meats (has, sausages and salami)

    Red meat contains a molecule humans do not naturally produce (Neu5Gc) that leads to the production of antibodies in defense of it, an immune response that may trigger chronic inflammation, and low grade inflammation (linked to heart disease and cancer)

Refined grains

Devoid of fiber and vitamin B compared with unrefined grains (have bran, germ and aleurone layer); refined grains like refined sugar with high glycemic index     When consistently consumed hasten onset heart disease and cancer    Also often laden with fat and sugar and artificial flavors and partially hydrogenated oil

Artificial food additives

    Aspartame and monosodium glutamate reportedly trigger inflammatory responses (particularly in those with inflammatory conditions, for example, rheumatoid arthritis

Sugars

    Trans fats (found in deep fried foods, commercially baked goods, and those prepared with partially dehydrongenated oil, margarine and vegetable shortening

In addition, in the interest of best practice, as primary nonpharmacologic practitioners, contemporary physical therapists are integrating into practice health education including initiating and supporting smoking cessation, improved sleep hygiene, and stress management [94]. Given that smoking, poor sleep, and stress are all associated with low-grade inflammation and hyperimmune response, team members such as nutritionists and health counselors could be used to greater advantage on the health care team to promote effective health education related to health behavior change. In acute conditions, such education needs to be introduced potentially with pharmacologic intervention to reduce inflammation and pain expediently. However, as the acute episode subsides and the condition stabilizes, medication needs to be reduced as much as possible, and perhaps completely, as health living practices take maximal effect.

The benefits of healthy living have no better been exemplified than in an elegant but simple study reported by Ford and colleagues [95]. In their study of over 23,000 people between 35 and 65 years old, they reported that over an eight-year period, people who did not smoke; had a body mass index of less than 30 kg·m²; were physically active for at least 3.5 hours weekly; and ate healthily reduced their risk of type 2 diabetes mellitus by 93%, myocardial infarction by 81%, stroke by 50%, and cancer by 36%. Even if not all four health behaviors were present, risk of developing a chronic lifestyle-related condition decreased commensurate with an increase in the number of positive lifestyle factors. Furthermore, health-related quality of life increased with the number of healthy lifestyle behaviors that participants reported. In the process of conducting the present review of the literature, we identified no medication that was associated with such outcomes and such low risk of side effects, if any.

In the interest of best practice, healthy living recommendations need to be prescribed as uniquely for their direct effects on the pathoetiology of osteoarthritis, and prescribed as aggressively as first-line medications. Although general health recommendations are important for health promotion and disease prevention generally, the tenets of healthy living need to be systematically targeted to the patient’s signs and symptoms and prescribed accordingly including long-term followup and support. Not doing so deprives the patient of evidence-informed best practice osteoarthritis management and care.

Consistent with healthy living as a first-line approach, patients’ health behaviors need to be assessed in a measurable, reproducible, and standardized manner. In addition to questionnaires and self-reports, despite their limitations, inflammatory biomarkers such as C-reactive protein may be useful to objectively measure the effects of lifestyle behavior change rather than simply as an index of cardiovascular and diabetes risk [96–99].

To address the reports of health care practitioners about lack of knowledge and confidence to effect health behavior change, they have a range of evidence-based interventions at their disposal that are not time or resource intense [100–102]. In addition, the 5’s approach of behavior change, for example, has some evidence base and has been endorsed by the World Health Organization [103]. Its simplicity makes it attractive to health professionals, that is, assess: evaluate behavior change status (and progress), advise: personally relevant behavioral recommendations, agree: set specific collaborative, feasible goals, assist: anticipate barriers, problem-solve solutions, and complete action plan, and arrange: schedule followup, contacts, and resources.

In the interest of best practice, lifestyle behaviors need to be systematically assessed in every patient and monitored across the health professions the patient is seeing. Healthy living recommendations need to be prescribed as uniquely for their direct effects on the pathoetiology of osteoarthritis as medications are, and as aggressively if first-line management is to truly reflect evidence-based practice. Although general recommendations are important for health promotion and disease prevention generally, healthy living recommendations must be systematically targeted to the patient’s signs and symptoms. In addition to integrating dietary and activity recommendations, smoking cessation, sleep hygiene, and stress reduction should be included in the interest of comprehensive effective care. Not doing so deprives the patient of best practice osteoarthritis management in relation to potential comorbidities that commonly present in this cohort.

5. Implications: Clinical and Research

The evidence supporting lifestyle behaviour change to address low-grade inflammation in people with osteoarthritis often with coexistent lifestyle-related risk factors and low-grade inflammatory conditions (specifically, anti-inflammatory nutritional regimens, and moderate physical activity) is unequivocal. The evidence is sufficiently compelling for related healthy living assessment and recommendations be a component of first-line best practice in the management of the signs and symptoms of people with osteoarthritis. Assessments need to include lifestyle profiles related to body mass index, waist girth, and waist-to-hip ratio; physical activity and exercise, as well as smoking, sleep patterns, and stress (as these three latter factors have also been reported to be proinflammatory). When quantified in standardized ways, these profiles can serve as clinical outcomes to assess health behavior change interventions. The health behaviour change literature has exploded over the past two decades, yet health professions report lack of confidence in effecting health behavior change in their patients, and lack of resources including time [100]. Although much needs to be done, evidence-based interventions can be readily integrated into the framework of clinical practice and patient visits [101, 104], for example, brief advice, referral to others professionals, and followup). Physical therapists are particularly well positioned for initiating and supporting health behavior change in that patient visits tend to be prolonged and protracted over time, elements that are critical to effective long-term sustained health behavior change.

Studies are needed to examine the differentiating characteristics of those people with osteoarthritis who respond primarily to optimal nutrition and moderate physical activity, and those who do not. In addition, the elements of an anti-inflammatory nutrition regimen and moderate physical activity program need to be refined in terms of their prescriptive parameters, specifically, which elements should be a primary focus for which patients. Another line of studies is needed to examine the effect of such healthy lifestyle choices that increase inflammation threshold, on the need for medication and, if medication is indicated, how might its potency and dosage be reduced. The interactions among healthy lifestyle behaviors and pharmacokinetics need to be elucidated. Given that chronic systemic low-grade inflammation has been reported to be a common denominator of lifestyle-related conditions, studies are needed to establish the degree to which their risk factors and manifestations are reduced in people with chronic osteoarthritis whose first-line management includes prescribing optimal nutrition and physical activity for their anti-inflammatory effects. Furthermore, the impact of low-grade inflammation can be more far reaching than physical complaints alone, in that even healthy older adults report poorer health commensurate with level of inflammatory markers [105]. Lastly, all indicators support that the approach to chronic progressive conditions such as osteoarthritis needs to be holistic and interprofessional [106]. Research is needed to capture the breadth of this evidence-informed practice approach.

6. Conclusion

Based on the extant literature, exploitation of anti-inflammatory lifestyle behavior change as ‘‘first-line’’ intervention in the management of chronic osteoarthritis could well constitute best practice. Chronic low-grade inflammation that has been reported in chronic osteoarthritis is comparable to other lifestyle-related conditions supporting a common mechanism of action. Addressing chronic low-grade inflammation by focussing on lifestyle factors that contribute directly to it holds the promise of increasing a patient’s inflammatory threshold, reducing rate of disease progression, reducing weight, and maximizing health by minimizing a patient’s risk or manifestations of other lifestyle-related conditions. Even in part, such outcomes could minimize demands on physicians for short-term symptom reduction, and management of the patient’s comorbidity related to lifestyle-related conditions. ‘‘First-line’’ lifestyle interventions to address chronic low-grade inflammation provides an informed cost-effective basis for the 21st century prevention, potential reversal, and management of chronic osteoarthritis. Exploitation of such ‘‘first-line’’ intervention, however, needs to be a goal shared and supported by all healthcare team members.

References

L. Brosseau, G. A. Wells, P. Tugwell et al., “Ottawapanel evidence-based clinical practice guidelines for the management of osteoarthritis in adults who are obese or overweight,” Physical Therapy, vol. 91, no. 6, pp. 843–860, 2011.

M. C. Hochberg, R. D. Altman, K. T. April et al., “American College of Rheumatology 2012. Recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee,” Arthritis Care Research, vol. 64, pp. 465–474, 2012.

N. E. Lane and J. M. Thompson, “Management of osteoarthritis in the primary-care setting: an evidence- based approach to treatment,” American Journal of Medicine A, vol. 103, no. 6, pp. 25S–30S, 1997.

Osteoarthritis, “National clinical guideline for care and management in adults,” The National Collaborative Centre for Chronic Conditions. Royal College of Physicians of London, http://bookshop.rcplondon.ac.uk/contents/pub242-66a1af7e-27ae-4121-bd84-6b503c80a64e.pdf, 2008

W. Zhang, G. Nuki, R. W. Moskowitz et al., “OARSI recommendations for the management of hip and knee osteoarthritis. Part III: changes in evidence following systematic cumulative update of research published through January 2009,” Osteoarthritis and Cartilage, vol. 18, no. 4, pp. 476–499, 2010.

A. Barr and P. G. Conaghan, “Osteoarthritis: a holistic approach,” Clinical Medicine, vol. 12, no. 2, pp. 153–155, 2012.

N. Hairon, “New guidance on osteoarthritis focuses on patient education,” Nursing times, vol. 104, no. 10, pp. 21–22, 2008.

R. I. Issa and T. M. Griffin, “Pathobiology of obesity and osteoarthritis: integrating biomechanics and inflammation,” Pathobiology of Aging and Age Related Diseases, vol. 2012, Article ID 17470, 2 pages, 2012.

D. L. Cecil, K. Johnson, J. Rediske, M. Lotz, A. M. Schmidt, and R. Terkeltaub, “Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products,” Journal of Immunology, vol. 175, no. 12, pp. 8296–8302, 2005.

J. Rojas-Rodríguez, L. E. Escobar-Linares, M. Garcia-Carrasco, R. O. Escárcega, S. Fuentes-Alexandro, and A. Zamora-Ustaran, “The relationship between the metabolic syndrome and energy-utilization deficit in the pathogenesis of obesity-induced osteoarthritis,” Medical Hypotheses, vol. 69, no. 4, pp. 860–868, 2007.

N. Schlesinger and R. G. Thiele, “The pathogenesis of bone erosions in gouty arthritis,” Annals of the Rheumatic Diseases, vol. 69, no. 11, pp. 1907–1912, 2010.

M. D. Smith, S. Triantafillou, A. Parker, P. P. Youssef, and M. Coleman, “Synovial membrane inflammation and cytokine production in patients with early osteoarthritis,” Journal of Rheumatology, vol. 24, no. 2, pp. 365–371, 1997.

E. Dean, S. Al-Obaidi, A. D. de Andrade et al., “The first physical therapy summit on global health: implications and recommendations for the 21st century,” Physiotherapy Theory and Practice, vol. 27, no. 8, pp. 531–547, 2011.

World Health Organization, Chronic Diseases, http://www.who.int/topics/chronic_diseases/en/, 2005

P. Carrera-Bastos, M. Fontes-Villalba, J. H. O. Keefe, S. Lindeberg, and L. Cordain, “The western diet and lifestyle and diseases of civilization,” Research Reports in Clinical Cardiology, vol. 2, pp. 15–35, 2012.

B. Caballero, “Obesity as a consequence of undernutrition,” Journal of Pediatrics, vol. 149, no. 3, pp. S97–S99, 2006.

G. Engström, M. Gerhardsson de Verdier, J. Rollof, P. M. Nilsson, and L. S. Lohmander, “C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study,” Osteoarthritis and Cartilage, vol. 17, no. 2, pp. 168–173, 2009.

L. Landaeta-Díaz, J. M. Fernández, M. Da Silva-Grigoletto et al., “Mediterranean diet, moderate-to-high intensity training and health-related quality of life in adults with metabolic syndrome,” European Journal of Preventive Cardiology. In press

T. C. Campbell, “A study on diet, nutrition and disease in the People's Republic of China. Part I,” Boletin de la Asociacion Medica de Puerto Rico, vol. 82, no. 3, pp. 132–134, 1990.

T. C. Campbell and C. Junshi, “Diet and chronic degenerative diseases: perspectives from China,” American Journal of Clinical Nutrition, vol. 59, supplement 1, pp. 1153S–1153S, 1994.

T. C. Campbell and T. M. Campbell, The China Study, Benbella Books, Dallas, Tex, USA, 2006.

T. C. Campbell, B. Parpia, and J. Chen, “Diet, lifestyle, and the etiology of coronary artery disease: the Cornell China Study,” American Journal of Cardiology B, vol. 82, no. 10, pp. 18T–21T, 1998.

S. Gregersen, D. Samocha-Bonet, L. K. Heilbronn, and L. V. Campbell, “Inflammatory and oxidative stress responses to high-carbohydrate and high-fat meals in healthy humans,” Journal of Nutrition and Metabolism, vol. 2012, Article ID 238056, 8 pages, 2012.

B. J. Nicklas, W. Ambrosius, S. P. Messier et al., “Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial,” American Journal of Clinical Nutrition, vol. 79, no. 4, pp. 544–551, 2004.

M. A. Allison, N. E. Jensky, S. J. Marshall, A. G. Bertoni, and M. Cushman, “Sedentary behavior and adiposity-associated inflammation: the multi-ethnic study of atherosclerosis,” American Journal of Preventive Medicine, vol. 42, no. 1, pp. 8–13, 2012.

M. Gleeson, N. C. Bishop, D. J. Stensel, M. R. Lindley, S. S. Mastana, and M. A. Nimmo, “The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease,” Nature Reviews Immunology, vol. 11, no. 9, pp. 607–615, 2011.

A. M. W. Petersen and B. K. Pedersen, “The anti-inflammatory effect of exercise,” Journal of Applied Physiology, vol. 98, no. 4, pp. 1154–1162, 2005.

Exercise helps ease arthritis pain and stiffness, http://www.mayoclinic.com/health/arthritis/AR00009, 2012

N. P. Walsh, M. Gleeson, R. J. Shephard et al., “Position statement. Part one: immune function and exercise,” Exercise Immunology Review, vol. 17, pp. 6–63, 2011.

M. Gurevich, P. M. Kohn, and C. Davis, “Exercise-induced analgesia and the role of reactivity in pain sensitivity,” Journal of Sports Sciences, vol. 12, no. 6, pp. 549–559, 1994.

R. B. Singh, G. Dubnov, M. A. Niaz et al., “Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial,” The Lancet, vol. 360, no. 9344, pp. 1455–1461, 2002.

J. Lee, V. Taneja, and R. Vassallo, “Cigarette smoking and inflammation cellular and molecular mechanisms,” Journal of Dental Research, vol. 91, no. 2, pp. 142–149, 2012.

R. B. Gonçalves, R. D. Coletta, K. G. Silvério et al., “Impact of smoking on inflammation: overview of molecular mechanisms,” Inflammation Research, vol. 60, no. 5, pp. 409–424, 2011.

A. Bakhru and T. P. Erlinger, “Smoking cessation and cardiovascular disease risk factors: results from the third national health and nutrition examination survey,” PLoS Medicine, vol. 2, no. 6, pp. 0528–0536, 2005.

Z. Baka, E. Buzás, and G. Nagy, “Rheumatoid arthritis and smoking: putting the pieces together,” Arthritis Research & Therapy, vol. 11, no. 4, p. 238, 2009.

S. Amin, J. Niu, A. Guermazi et al., “Cigarette smoking and the risk for cartilage loss and knee pain in men with knee osteoarthritis,” Annals of the Rheumatic Diseases, vol. 66, no. 1, pp. 18–22, 2007.

P. H. Black, “Stress and the inflammatory response: a review of neurogenic inflammation,” Brain, Behavior, and Immunity, vol. 16, no. 6, pp. 622–653, 2002.

P. H. Black, “The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X,” Brain, Behavior, and Immunity, vol. 17, no. 5, pp. 350–364, 2003.

S. Cohen, D. Janicki-Deverts, W. J. Doyle et al., “Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk,” Proceedings of the National Academy of Science, vol. 109, no. 16, pp. 5995–5999, 2012.

M. Maes, “Psychological stress and the inflammatory response system,” Clinical Science, vol. 101, no. 2, pp. 193–194, 2001.

T. Pedersen, “Lack of sleep, stress leads to inflammation in older adults,” Psychology Central, http://psychcentral.com/news/2012/03/02/lack-of-sleep-stress-leads-to-inflammation-in-older-adults/35490.html, 2012

B. Giunta, F. Fernandez, W. V. Nikolic et al., “Inflammaging as a prodrome to Alzheimer's disease,” Journal of Neuroinflammation, vol. 5, p. 51, 2008.

R. Veerhuis, “Histological and direct evidence for the role of complement in the neuroinflammation of AD,” Current Alzheimer Research, vol. 8, no. 1, pp. 34–58, 2011.

G. Candore, C. Caruso, E. Jirillo, T. Magrone, and S. Vasto, “Low grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement,” Current Pharmaceutical Design, vol. 16, no. 6, pp. 584–596, 2010.

K. T. Chou, C. C. Huang, Y. M. Chen et al., “Asthma and risk of erectile dysfunction-A nationwide population-based study,” Journal of Sexual Medicine, vol. 8, no. 6, pp. 1754–1760, 2011.

A. Dixon, “The treatment of asthma in obesity,” Expert Reviews in Respiratory Medicine, vol. 6, no. 3, pp. 331–340, 2012.

C. T. Juel, Z. Ali, L. Nilas, and C. S. Ulrik, “Asthma and obesity: does weight loss improve asthma control? A systematic review,” Journal of Asthma and Allergy, vol. 5, pp. 21–26, 2012.

H. F. Gu, C. K. Tang, and Y. Z. Yang, “Psychological stress, immune response, and atherosclerosis,” Atherosclerosis, vol. 223, no. 1, pp. 69–77, 2012.

E. J. Kucharz, “Chronic inflammation-enhanced atherosclerosis: can we consider it as a new clinical syndrome?” Medical Hypotheses, vol. 78, no. 3, pp. 396–397, 2012.

X. T. Lu, Y. F. Liu, L. Zhang et al., “Unpredictable chronic mild stress promotes atherosclerosis in high cholesterol-fed rabbits,” Psychosomatic Medicine, vol. 74, no. 6, pp. 604–611, 2012.

E. Ortega, R. Gilabert, I. Nuñez et al., “White blood cell count is associated with carotid and femoral atherosclerosis,” Atherosclerosis, vol. 221, no. 1, pp. 275–281, 2012.

A. Pinto, D. Di Raimondo, A. Tuttolomondo, C. Buttà, G. Milio, and G. Licata, “Effects of physical exercise on inflammatory markers of atherosclerosis,” Current Pharmaceutical Design, vol. 18, no. 28, pp. 4326–4349, 2012.

P. Correa and M. B. Piazuelo, “The gastric precancerous cascade,” Journal of Digestive Diseases, vol. 13, no. 1, pp. 2–9, 2012.

S. Peters, N. Grunwald, P. Rümmele et al., “Chronic psychosocial stress increases the risk for inflammation-related colon carcinogenesis in male mice,” Stress, vol. 15, no. 4, pp. 403–415, 2012.

L. A. Cox Jr, “Dose-response thresholds for progressive diseases,” Dose Response, vol. 10, no. 2, pp. 233–250, 2012.

A. Lindberg, L. G. Larsson, E. Rönmark, and B. Lundbäck, “Co-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung function,” Chronic Obstructive Pulmonary Disease, vol. 8, no. 6, pp. 421–428, 2011.

N. H. T. ten Hacken, “Physical inactivity and obesity: relation to asthma and chronic obstructive pulmonary disease?” Proceedings of the American Thoracic Society, vol. 6, no. 8, pp. 663–667, 2009.

E. F. M. Wouters, N. L. Reynaert, M. A. Dentener, and J. H. J. Vernooy, “Systemic and local inflammation in asthma and chronic obstructive pulmonary disease is there a connection?” Proceedings of the American Thoracic Society, vol. 6, no. 8, pp. 638–647, 2009.

C. M. Chang, C. J. Hsieh, J. C. Huang, and I. C. Huang, “Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus,” Acta Diabetologica, vol. 49, no. 1 Supplement, pp. 171–177, 2012.

B. C. van Bussel, S. S. Soedamah-Muthu, R. M. Henry et al., “EURODIAB Prospective Complications Study Group, Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: The EURODIAB study,” Nutrition and Metabolism in Cardiovascular Disease. In press

D. Kadetoff, J. Lampa, M. Westman, M. Andersson, and E. Kosek, “Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels,” Journal of Neuroimmunology, vol. 242, no. 1-2, pp. 33–38, 2012.

E. Ortega, M. E. Bote, E. Giraldo, and J. J. García, “Aquatic exercise improves the monocyte pro- and anti-inflammatory cytokine production balance in fibromyalgia patients,” Scandinavian Journal of Medical Science and Sports, vol. 22, no. 1, pp. 104–112, 2012.

A. Berni, E. Ciani, M. Bernetti et al., “Renal resistive index and low-grade inflammation in patients with essential hypertension,” Journal of Human Hypertension, vol. 26, no. 12, pp. 723–730, 2012.

H. He, Z. Zhao, J. Chen et al., “Metformin-based treatment for obesity-related hypertension: a randomized, double-blind, placebo-controlled trial,” Journal of Hypertension, vol. 30, no. 7, pp. 1430–1439, 2012.

F. Sari, E. Eray, and R. Sari, “The effect of quinapril treatment on insulin resistance, leptin and high sensitive C-reactive protein in hypertensive patients,” Clinical Experimental Hypertension, vol. 33, no. 8, pp. 548–551, 2011.

T. Sugiura, Y. Dohi, S. Yamashita et al., “Impact of lipid profile and high blood pressure onendothelial damage,” Journal of Clinical Lipidology, vol. 5, no. 6, pp. 460–466, 2011.

M. K. Piya, P. G. McTeman, and S. Kumar, “Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin,” Journal of Endocrinology. In press

S. E. Shoelson, J. Lee, and A. B. Goldfine, “Inflammation and insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793–1801, 2006.

D. I. Simon, “Inflammation and vascular injury,” Circulation Journal, vol. 76, no. 8, pp. 1811–1818, 2012.

A. P. Kalogeropoulos, V. V. Georgiopoulou, and J. Butler, “From risk factors to structural heart disease: the role of inflammation,” Heart Fail Clinics, vol. 8, no. 1, pp. 113–123, 2012.

E. Vizzardi, I. Bonadei, B. Piovanelli et al., “Helicobacter pylori and ischemic heart disease,” Panminerva Medica, vol. 53, no. 3, pp. 193–202, 2011.

H. T. Kang, J. K. Kim, J. Y. Shim, H. R. Lee, J. A. Linton, and Y. J. Lee, “Low-grade inflammation, metabolic syndrome and the risk of chronic kidney disease: the 2005 Korean national health and nutrition examination survey,” Journal of Korean Medical Science, vol. 27, no. 6, pp. 630–635, 2012.

I. Kocyigit, M. G. Kaya, O. Orscelik et al., “Early arterial stiffness and inflammatory bio-markers in normotensive polycystic kidney disease patients,” American Journal of Nephrology, vol. 36, no. 1, pp. 11–18, 2012.

D. Luis-Rodríguez, A. Martínez-Castelao, J. L. Górriz, F. De-Álvaro, and J. F. Navarro-González, “Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy,” World Journal of Diabetes, vol. 3, no. 1, pp. 7–18, 2012.

J. Tang, H. Yan, and S. Zhuang, “Inflammation and oxidative stress in obesity-related glomerulopathy,” International Journal of Nephrology, vol. 2012, Article ID 608397, 11 pages, 2012.

M. Hulsmans, B. Geeraert, D. De Keyzer et al., “Interleukin-1 receptor-associated kinase-3 is a key inhibitor of inflammation in obesity and metabolic syndrome,” PLoS One, vol. 7, no. 1, Article ID e30414, 2012.

M. G. Rico-Rosillo and G. B. Vega-Robledo, “New trends in macrophages, inflammation and adipose tissue,” Revista Médica del Instituto Mexicano del Seguro Social, vol. 50, no. 1, pp. 39–45, 2012.

R. Stienstra, C. Duval, M. Müller, and S. Kersten, “PPARs, obesity, and inflammation,” PPAR Research, Article ID 95974, 2007.

N. Tajik, S. A. Keshavarz, F. Masoudkabir et al., “Effect of diet-induced weight loss on inflammatory cytokines in obese women,” Journal of Endocrinological Investigations. In press

E. Gremese and G. Ferraccioli, “The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk,” Autoimmunity Reviews, vol. 10, no. 10, pp. 582–589, 2011.

M. Prete, V. Racanelli, L. Digiglio, A. Vacca, F. Dammacco, and F. Perosa, “Extra-articular manifestations of rheumatoid arthritis: an update,” Autoimmunology Review, vol. 11, no. 2, pp. 123–131, 2011.

A. Denes, E. Pinteaux, N. J. Rothwell, and S. M. Allan, “Interleukin-1 and stroke: biomarker, harbinger of damage, and therapeutic target,” Cerebrovascular Disease, vol. 32, no. 6, pp. 517–527, 2011.

C. W. Wu, P. Z. Chao, W. R. Hao, T. H. Liou, and H. W. Lin, “Risk of stroke among patients with rhinosinusitis: a population-based study in Taiwan,” American Journal of Rhinological Allergy, vol. 26, no. 4, pp. 278–282, 2012.

A. Powell, A. J. Teichtahl, A. E. Wluka, and F. M. Cicuttini, “Obesity: a preventable risk factor for large joint osteoarthritis which may act through biomechanical factors,” British Journal of Sports Medicine, vol. 39, no. 1, pp. 4–5, 2005.

L. Beck, Foods that Fight Disease. A Nutrition Guide for Staying Healthy for Life, Penguin Canada, Toronto, Canada, 2010.

J. Daniluk, Meals that Heal Inflammation. Embrace Healthy Living and Eliminate Pain, One Meal at a Time, Random House Canada, Toronto, Canada, 2011.

A. W. Weil, Anti Inflammatory Diet and Pyramid, http://www.drweil.com/drw/u/ART02012/anti-inflammatory-diet, 2012

Meeting the challenge of living well at a glance 2012, Centers for Disease Control and Prevention, http://www.cdc.gov/chronicdisease/resources/publications/AAG/arthritis.htm, 2012

B. E. Wisse, “The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity,” Journal of the American Society of Nephrology, vol. 15, no. 11, pp. 2792–2800, 2004.

R. Liu, N. Wei, W. Guo et al., “Octreotide alleviates obesity by reducing intestinal glucose absorption and inhibiting low-grade inflammation,” European Journal of Nutrition. In press

E. Dean, “Physical therapy in the 21st century (Part II): evidence-based practice within the context of evidence-informed practice,” Physiotherapy Theory and Practice, vol. 25, no. 5-6, pp. 354–368, 2009.

W. Frerichs, E. Kaltenbacher, J. P. van de Leur, and E. Dean, “Can physical therapists counsel patients with lifestyle-related health conditions effectively? A systematic review and implications,” Physiotherapy Theory and Practice, vol. 28, no. 8, pp. 571–587, 2012.

World Health Organization, International Classification of Functioning, Disability and Health, http://www.sustainable-design.ie/arch/ICIDH-2PFDec-2000.pdf, 2002

S. Hasson, “Editorial-special issue ‘physical therapy practice in the 21st century: a new evidence-informed paradigm and implications’,” Physiotherapy Theory and Practice, vol. 25, no. 5-6, pp. 327–462, 2009.

E. S. Ford, M. M. Bergmann, J. Kröger, A. Schienkiewitz, C. Weikert, and H. Boeing, “Healthy living is the best revenge: findings from the European prospective investigation into cancer and nutrition-potsdam study,” Archives of Internal Medicine, vol. 169, no. 15, pp. 1355–1362, 2009.

P. M. Ridker, “High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease,” Circulation, vol. 103, no. 13, pp. 1813–1818, 2001.

P. M. Ridker, “Clinical application of C-reactive protein for cardiovascular disease detection and prevention,” Circulation, vol. 107, no. 3, pp. 363–369, 2003.

P. M. Ridker, M. Cushman, M. J. Stampfer, R. P. Tracy, and C. H. Hennekens, “Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men,” New England Journal of Medicine, vol. 336, no. 14, pp. 973–979, 1997.

P. M. Ridker, C. H. Hennekens, J. E. Buring, and N. Rifai, “C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women,” New England Journal of Medicine, vol. 342, no. 12, pp. 836–843, 2000.

M. Bodner, R. E. Rhodes, W. C. Miller, and E. Dean, “Smoking cessation and counselling: practices of Canadian physical therapists,” American Journal of Preventive Medicine, vol. 43, no. 1, pp. 67–71, 2012.

E. Dean, Z. Li, W. P. Wong, and M. E. Bodner, “Cardiology best practice-effective health education meets biomedical advances: reducing the ultimate knowledge translation gap,” in Novel Strategies in Ischemic Heart Disease, U. Lakshmanadoss, Ed., pp. 301–318, InTech Publishing, Rijeka, Croatia, 2012.

R. K. Martins and D. W. McNeil, “Review of Motivational Interviewing in promoting health behaviors,” Clinical Psychology Review, vol. 29, no. 4, pp. 283–293, 2009.

“The 5 A's Cycle,” World Health Organization, http://www.who.int/diabetesactiononline/about/WHO%205A%20ppt.pdf, 2004

T. van Achterberg, G. G. J. Huisman-De Waal, N. A. B. M. Ketelaar, R. A. Oostendorp, J. E. Jacobs, and H. C. H. Wollersheim, “How to promote healthy behaviours in patients? An overview of evidence for behaviour change techniques,” Health Promotion International, vol. 26, no. 2, pp. 148–162, 2011.

L. M. Christian, R. Glaser, K. Porter, W. B. Malarkey, D. Beversdorf, and J. K. Kiecolt-Glaser, “Poorer self-rated health is associated with elevated inflammatory markers among older adults,” Psychoneuroendocrinology, vol. 36, no. 10, pp. 1495–1504, 2011.

A. Barr and P. G. Conaghan, “Osteoarthritis: a holistic approach,” Clinical Medicine, vol. 12, no. 2, pp. 153–155, 2012.